Skip to content

The Actual News

Stay informed without the news wearing you out.

Court approves $7.25 billion Bayer settlement over claims Roundup weed killer caused cancer

Court approves $7.25 billion Bayer settlement over claims Roundup weed killer caused cancer

Summary

A Missouri judge approved a settlement under which Bayer could pay up to $7.25 billion over 20 years to resolve thousands of U.S. claims linking Roundup to non-Hodgkin lymphoma. The deal covers people already diagnosed and people diagnosed in future years, while Bayer continues to deny that Roundup causes cancer.

Key Facts

  • The nationwide settlement covers current and future U.S. claims involving non-Hodgkin lymphoma.
  • Eligible participants could receive an average of $10,000 to $165,000, based on factors including product use, age at diagnosis, and illness severity.
  • Bayer acquired Roundup when it bought Monsanto in 2018.
  • Glyphosate is Roundup’s active ingredient.
  • The World Health Organization’s cancer research agency classified glyphosate as probably carcinogenic in 2015.
  • The U.S. Environmental Protection Agency has said glyphosate is not likely to cause cancer in humans when used as directed.
  • About 200,000 Roundup-related claims have been made against Bayer.
  • The settlement approval could be appealed.
Read the Full Article

This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.

The week's biggest stories, one calm email every Monday.